Wanderlust Partners with Wim Hof for the Wellspring Wanderlust x Wim Hof Experience 2025
10 months ago
United Kingdom Professor Sarah Gilbert specializes in the development of viral vectored vaccines and has played a key role in public health initiatives.
New partnership aims to advance vaccine against MERS ... The project will see CEPI, Barinthus Bio, an Oxfordshire-based clinical-stage biopharmaceutical company ... Professor Dame Sarah Gilbert, Pandemic ...
Professor Gilbert is Professor of Vaccinology at the University of Oxford and leads programmes on the development of vaccines against multiple emerging viral ...
Bvlgari, the Italian luxury brand, has today announced plans to support research into COVID-19 and vaccine development at Oxford University.
The Professor of Vaccinology is named a 2021 Role Model as brand celebrates women in STEM's achievements during the pandemic.
On 30 December 2020, the Oxford–AstraZeneca COVID-19 vaccine she co-developed with the Oxford Vaccine Group was approved for use in the UK. More than 3 billion ...
Professor Dame Sarah Gilbert joined the Nuffield Department of Medicine at Oxford University in 1994. In 2005, she became part of the Jenner Institute, focusing her research on the development of viral vectored vaccines. Her work involves inducing strong and protective T and B cell responses to combat infectious diseases. She leads projects on influenza vaccine development and vaccines for emerging pathogens such as Nipah virus, MERS, and Lassa virus. Her efforts also include the rapid transfer of vaccines into GMP manufacturing and initial human trials, collaborating with the Clinical Biomanufacturing Facility and the Centre for Clinical Vaccinology and Tropical Medicine at Oxford.
In 2020, Professor Gilbert took on the role of Oxford Project Leader for ChAdOx1 nCoV-19, a vaccine designed to combat the SARS-CoV-2 coronavirus. This vaccine underwent clinical trials with over 23,000 participants across the UK, Brazil, and South Africa. Following its successful development and trials, it has been deployed globally as a critical tool in managing the Covid-19 Pandemic. For her contributions to science and public health, she was honored with the Dame Commander of the Most Excellent Order of the British Empire (DBE).
Her career has been marked by a commitment to addressing global health challenges through vaccine innovation. This dedication enabled the accelerated development of a COVID-19 vaccine, demonstrating the impact of focused research and collaborative efforts in times of urgent public health need. Her expertise in vaccinology has made substantial contributions to the field of infectious disease prevention.
Curious about our offerings or have inquiries? We're eager to assist!
Just complete the form, and we'll respond promptly.
